NasdaqGM - Nasdaq Real Time Price USD
Phibro Animal Health Corporation (PAHC)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 5:49 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 0.25 | 0.41 | 1.55 | 1.92 |
| Low Estimate | 0.2 | 0.32 | 1.3 | 1.55 |
| High Estimate | 0.3 | 0.49 | 1.81 | 2.15 |
| Year Ago EPS | 0.14 | 0.33 | 1.19 | 1.55 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 4 |
| Avg. Estimate | 246.6M | 287.26M | 1.21B | 1.39B |
| Low Estimate | 243M | 263M | 1.05B | 1.06B |
| High Estimate | 250.2M | 311.53M | 1.44B | 1.5B |
| Year Ago Sales | 231.35M | -- | 1.02B | 1.21B |
| Sales Growth (year/est) | 6.60% | -- | 19.30% | 14.30% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.23 | 0.28 | 0.29 | 0.33 |
| EPS Actual | 0.14 | 0.33 | 0.31 | 0.41 |
| Difference | -0.09 | 0.05 | 0.02 | 0.08 |
| Surprise % | -39.10% | 17.90% | 6.90% | 24.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.25 | 0.41 | 1.55 | 1.92 |
| 7 Days Ago | 0.25 | 0.41 | 1.55 | 1.92 |
| 30 Days Ago | 0.23 | 0.38 | 1.42 | 1.74 |
| 60 Days Ago | 0.31 | 0.42 | 1.38 | 1.59 |
| 90 Days Ago | 0.31 | 0.42 | 1.47 | 1.73 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 2 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PAHC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 78.60% | -- | -- | 3.60% |
| Next Qtr. | 24.20% | -- | -- | 7.90% |
| Current Year | 30.30% | -- | -- | 2.50% |
| Next Year | 23.90% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 8.10% | -- | -- | 11.87% |
| Past 5 Years (per annum) | 1.54% | -- | -- | -- |
Upgrades & Downgrades
| Initiated | JP Morgan: Neutral | 9/10/2024 |
| Maintains | B of A Securities: Underperform to Underperform | 8/30/2024 |
| Maintains | Barclays: Underweight to Underweight | 5/10/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/9/2023 |
| Reiterates | Roth MKM: Buy to Buy | 9/1/2023 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 8/31/2023 |
Related Tickers
CTLT Catalent, Inc.
60.18
-0.18%
PETQ PetIQ, Inc.
30.97
+0.13%
ELAN Elanco Animal Health Incorporated
12.62
-2.70%
INDV Indivior PLC
8.27
-3.39%
COLL Collegium Pharmaceutical, Inc.
36.46
-5.15%
KNSA Kiniksa Pharmaceuticals International, plc
25.89
-1.43%
ZTS Zoetis Inc.
189.45
-1.98%
SNOA Sonoma Pharmaceuticals, Inc.
2.9700
-6.01%
ORGO Organogenesis Holdings Inc.
3.1100
-1.58%
LEEEF Leef Brands Inc.
0.0190
+2.70%